Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis
Benjamin Meir Jacobs, Thomas R. Taylor, Amine Awad, et al.
Brain Communications (2020) Vol. 2, Iss. 2
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis
Jianfeng Lin, Jiawei Zhou, Yan Xu
Brain (2023) Vol. 146, Iss. 8, pp. 3364-3372
Open Access | Times Cited: 162
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Catherine S. Storm, Demis A. Kia, Mona Mohammad Almramhi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 126
Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease
Emrin Horgusluoglu, Ryan Neff, Won‐Min Song, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 6, pp. 1260-1278
Open Access | Times Cited: 108
Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn’s disease: a multi-omics Mendelian randomization study
Shu Xu, Xiaozhi Li, Shenghong Zhang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 104
Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases
Yuanhao Yang, Hannah Musco, Steve Simpson, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 81
Integrating network pharmacology with molecular docking and dynamics to uncover therapeutic targets and signaling mechanisms of vitamin D3 in Parkinson’s disease
Cheng Wang, Yiling Wang, Qiu-Han Xu
Molecular Diversity (2025)
Closed Access | Times Cited: 1
Genetics and functional genomics of multiple sclerosis
Woori Kim, Nikolaos A. Patsopoulos
Seminars in Immunopathology (2022) Vol. 44, Iss. 1, pp. 63-79
Closed Access | Times Cited: 19
Endoplasmic reticulum stress related genome-wide Mendelian randomization identifies therapeutic genes for ulcerative colitis and Crohn’s disease
Menglong Zou, Qiaoli Liang, Wei Zhang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 12
An Overview of Epigenetic Changes in the Parkinson’s Disease Brain
Anthony Klokkaris, Anna Migdalska‐Richards
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6168-6168
Open Access | Times Cited: 4
Mendelian randomization identifies proteins involved in neurodegenerative diseases
Lazaros Belbasis, Sam Morris, Cornelia M. van Duijn, et al.
Brain (2025)
Closed Access
Therapeutic Targets for Multiple System Atrophy
D S Fan, Jianhui Dai, Li Zhang, et al.
Research Square (Research Square) (2025)
Closed Access
Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis
Lorena Lorefice, Maristella Pitzalis, Federica Murgia, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 10
Whole-genome sequencing analysis of suicide deaths integrating brain-regulatory eQTLs data to identify risk loci and genes
Seonggyun Han, Emily DiBlasi, Eric T. Monson, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3909-3919
Open Access | Times Cited: 7
Novel DNA methylation loci and genes showing pleiotropic association with Alzheimer’s dementia: a network Mendelian randomization analysis
Di Liu, Youxin Wang, Huiquan Jing, et al.
Epigenetics (2021) Vol. 17, Iss. 7, pp. 746-758
Open Access | Times Cited: 14
A Mendelian randomization study identifies proteins involved in neurodegenerative diseases
Lazaros Belbasis, Sam Morris, Cornelia M. van Duijn, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis
Vivien Li, Michele D. Binder, Anthony W. Purcell, et al.
Journal of Neuroimmunology (2024) Vol. 390, pp. 578347-578347
Closed Access | Times Cited: 1
Integrated analyses of single-cell transcriptome and Mendelian randomization reveal the protective role of FCRL3 in multiple sclerosis
Kefu Yu, Ruiqi Jiang, Ziming Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
GNLY as a novel cis-eQTL and cis-pQTL mediated susceptibility gene in suppressing prostatitis. Mendelian randomization study
Yi Wang, Hao Ji, Guihua Chen, et al.
Archives of Medical Research (2024) Vol. 56, Iss. 2, pp. 103098-103098
Closed Access | Times Cited: 1
Genome-Wide Gene-Set Analysis Identifies Molecular Mechanisms Associated with ALS
Christina Vasilopoulou, Sarah L. McDaid-McCloskey, Gavin McCluskey, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4021-4021
Open Access | Times Cited: 2
Impact of multiple sclerosis risk alleles on the plasma proteome
Shannon A. Bernard Healey, Gavin Giovannoni, Alastair Noyce, et al.
Brain (2023) Vol. 147, Iss. 2, pp. e17-e21
Closed Access | Times Cited: 2
Identifying genetically-supported drug repurposing targets for non-small cell lung cancer through mendelian randomization of the druggable genome
Yi Feng, Caichen Li, Bo Cheng, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 8, pp. 1780-1793
Open Access
Multi-Omics Integration Prioritizes Potential Drug Targets for Multiple Sclerosis
Yuan Jiang, Qianwen Liu, Pernilla Stridh, et al.
(2024)
Closed Access
Genomic risk factors in multiple sclerosis
Jennifer Slough
British Journal of Neuroscience Nursing (2024) Vol. 20, Iss. Sup4, pp. S5-S6
Closed Access
Multi-omics integration prioritizes potential drug targets for multiple sclerosis
Yuan Jiang, Qianwen Liu, Pernilla Stridh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mendelian randomization and Parkinson’s disease
Arinola O. Sanyaolu, Wael Mohamed, Mary B. Makarious, et al.
Elsevier eBooks (2024), pp. 49-74
Closed Access
Page 1 - Next Page

Scroll to top